Description
This meeting will review the importance of efficient cytokine detection in translational medicine from the bench to bedside. From basic research to clinical trials the optimal way to assess cytokine levels will be discussed evaluating relatively low-tech methods such as ELISA to high throughput multiplex platform technologies. The best way to evaluate cytokines as mediators of pathology, as immunotherapeutics and as biomarkers will be addressed
This event has CPD accreditation and will have a troubleshooting panel session.
On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event
